Moffitt Cancer Center Executive Leadership


John A. (Jack) Kolosky, CPA, MBA

Chief Operating Officer and President of Moffitt Hospital

Jack Kolosky is Chief Operating Officer of Moffitt Cancer Center in Tampa, FL, and serves as the President of Moffitt Hospital. He joined the Cancer Center in November 1999.

Mr. Kolosky is responsible for ensuring that high quality care is provided to its many patients and that the Cancer Center is compliant with regulatory agencies and accrediting bodies, continually monitoring Moffitt's service and delivery systems. Mr. Kolosky also has the role of corporate Executive Vice President/Chief Operating Officer, where he oversees Patient Care Services as well as corporate functions as Information Technology, Internal Audit and Facilities and Support Services.

Mr. Kolosky has more than 30 years of health care leadership experience, including multiple hospital environments, clinic settings and academic, tertiary health care delivery systems. Prior to coming to Moffitt, he served as the Chief Financial Officer for the Georgetown University Medical Center in Washington, D.C., and as the Associate Vice President and Chief Financial Officer of the University of Texas M. D. Anderson Cancer Center in Houston, Texas.

Mr. Kolosky received his bachelor's degree in Accounting from Western Illinois University and an MBA in Finance from Drake University. He holds a Certificate from the Harvard University School of Public Health and is a Certified Public Accountant.

Mr. Kolosky is a Fellow in the Healthcare Financial Management Association, a member of the American College of Healthcare Executives, and is active in a number of other professional organizations. He serves on the board of directors of Moffitt Genetics Corporation (M2Gen), the Tampa Bay Partnership and is the past chair of Chapters Health System (the parent corporation of LifePath Hospice). Mr. Kolosky is currently the Board Chair of the Alliance of Dedicated Cancer Centers and the Board Chair of the Florida Hospital Association. He previously served on the board of the Nevada Cancer Institute.